Tuesday, November 07, 2006 7:45:00 AM PDT | VentureDeal Staff
iCardiac Technologies, Inc., announced
that it has closed its Series A round by getting an additional $2 million
investment. Total investment for the round was $4 million.
iCardiac was formed earlier this year to commercialize technologies licensed
from the University of Rochester that enable the identification of biomarkers
in drugs that would increase cardiac risks.
Investors Advantage Capital Partners
and Stonehenge Capital Company
led the round and invested in conjunction with New York's Certified Capital Companies
Email Page | Print Page
Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?
Start your Free 14 Day Trial now – no obligation or credit card required.
VentureDeal is a database that provides the latest information about venture capital firms, venture-backed technology companies and transactions throughout North America.
Learn More »
Email Sign Up
© 2014 VentureDeal, Inc., Menlo Park, CA. All Rights Reserved.